DermaGen AB is an Operating Unit within Pergamum AB – a new kind of biopharmaceutical company focusing solely on dermatology and wound healing markets. Pergamum currently has four Operating Units, which it supports with strategic management, business development, drug development and operational assistance as required.
Pergamum is a Karolinska Development AB company, making it part of one of the largest life science portfolios in Europe.